Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – has announced that the US Food and Drug Administration (FDA) has issued a ...
Illustration of main trading floor and digital index display screen at the Indonesia Stock Exchange (IDX) building in Jakarta. Tempo/Tony Hartawan TEMPO.CO, Jakarta - The Indonesia Stock Exchange (IDX ...
A high-level overview of Alphabet Inc. DEP SHS RP1/20 A (GOOGM) stock. View (GOOGM) real-time stock price, chart, news, analysis, analyst reviews and more.
Riyadh, July 22, 2025, SPA -- The Real Estate General Authority (REGA) concluded the second edition of the “Real Estate Brokerage Forum 2025,” held at the Riyadh International Convention and ...
FDA granted accelerated approval Thursday (Aug. 5) of Replimune’s gene therapy for advanced melanoma, a major reversal for a drug that was rejected by the agency twice, with a third rejection ...